Producers of genetically modified salmon might have difficulty finding acceptance in restaurants even if the U.S. Food and Drug Administration deems the fish fit for human consumption. The FDA said a 60-day consultation period will begin Sept. 19 and include a series of public meetings as the agency decides whether to allow the fish to be sold as food. If it wins approval, the fish should be available by 2012. The salmon was developed by AquaBounty Technologies Inc. of Waltham, Mass., and ...
Register to view this article
It’s free but we need to know a little about you to continually improve our content.
Registering allows you to unlock a portion of our premium online content. You can access more in-depth stories and analysis, as well as news not found on any other website or any other media outlet. You also get free eNewsletters, blogs, real-time polls, archives and more.
Attention Print Subscribers: While you have already been granted free access to NRN we ask that you register now. We promise it will only take a few minutes!
Questions about your account or how to access content?